Remove Diabetes Remove Generic Medicine Remove Immunization
article thumbnail

M&A trends to watch out in pharma

Express Pharma

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

article thumbnail

M&A trends to watch out in pharma

Express Pharma

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Risk adjusted net present value: What is the current valuation of Novartis’s Gevokizumab?

Pharmaceutical Technology

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

article thumbnail

Waters, as a strategic partner to the pharma industry, can help India become a world leader in biosimilars

Express Pharma

India is known as the ‘Pharmacy of the World’, as the generic medicine supplier for over 200 countries, both developed and emerging markets. A large presence of local players producing branded generics, along with lower price levels, has provided India with a unique opportunity. How poised are you to leverage them?

article thumbnail

Cracking the code – Generic vs. Brand Medicines

Express Pharma

So, the government shouldered the responsibility of manufacturing all basic essential antibiotics and medicines. Karnataka Antibiotics, and Bengal Immunity, etc. ” After shifting the focus to a “market-based economy,” the government’s medicine policies became more liberal, generous, and pro-industry.